DUBLIN–(BUSINESS WIRE)–The “Single-use Bioreactors Market Size, Share & Trends Analysis Report” report has been added to ResearchAndMarkets.com’s offering.
The global single-use bioreactors market size is expected to reach USD 12.06 billion by 2030, registering a CAGR of 17.19% from 2023 to 2030.
Owing to the rising demand for biopharmaceuticals, coupled with increasing investments in single-use technologies, the market for single-use bioreactors is expected to witness significant growth throughout the forecast period.
Furthermore, the COVID-19 outbreak has positively impacted the market for SUBs. The race to create an effective vaccine against the SARS-CoV-2 virus is being undertaken by numerous biopharmaceutical firms. As a result, the need for single-use bioreactors has drastically increased. For instance, in October 2020, ABEC supplied six 4,000 L single-use bioreactors to the Serum Institute of India, for the production of COVID-19 vaccines on a large scale at a reasonable cost.
The value of the product, the time required for product development and production, in addition to the criticality of the phase are now influencing the industry’s propensity to employ single-use bioreactors. In addition, the medical industry has a significant demand for these single-use bioreactors. As a result, pharmaceutical companies use these reactors to make medicines without having to compromise on their quality.
The flexibility of using single-use bioreactors is one of their main benefits. The growing trend toward multi-drug facilities necessitates the manufacture of various medications utilizing the same facility, in the shortest amount of time, and for the least amount of money. Thus, it will increase the demand for single-use bioreactors and further fuel market growth.
Single-use Bioreactors Market Report Highlights
- By product, the single-use bioreactor systems segment held the dominant share in 2022. The availability of disposable bioprocess bags in different sizes for a variety of uses, including the storage of reagents, buffers, sterile medium, sera, and cell cultures, is predicted to drive the market’s expansion
- By type, the stirred tank bioreactors segment held a larger market share in 2022, driven by the increasing adoption of stirred tank SUBs from pilot scale to large scale manufacturing, which is anticipated to boost the market growth in the forecast years
- Based on the type of cell, the mammalian cells segment held a larger share in 2022. The segment is being driven by the increasing usage of single-use bioreactors for mammalian cell culture in several research studies. This is another key factor expected to drive market growth significantly in the coming years
- By molecule type insights, the vaccines segment held a larger share in 2022. This is due to the less expensive nature and availability in smaller volumes. This allows manufacturers to test different cell lines as well as growth conditions more quickly and at a lower cost to improve vaccine manufacturing
- By usage insights, the lab-scale production segment held a larger share in 2022. Various types of waste creation and bioreactor operations are included in controlled laboratory-scale studies before scaling up. Due to such advantages offered by lab-scale bioreactors, the market is expected to grow during the forecast period
- North America held the largest market share in 2022. The North American market is predicted to be driven due to the presence of key players and the well-established biopharmaceutical industry in the region
- Asia Pacific is expected to expand at the highest rate in the forecast period. Factors such as rising investments and funding initiatives among Asian companies are expected to drive the market in the region. Furthermore, China is expected to be at the forefront owing to the high adoption of single-use technology in the country
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 160 |
| Forecast Period | 2022 – 2030 |
| Estimated Market Value (USD) in 2022 | $3304.1 Million |
| Forecasted Market Value (USD) by 2030 | $12060 Million |
| Compound Annual Growth Rate | 17.1% |
| Regions Covered | Global |
Market Dynamics
Drivers
- Increasing adoption of SUBs among small companies and startups
- Reduction in automation complexity
- Reduction in energy and water consumption
- Rising research in biopharmaceutical market
- Technological advancements in SUBs
Restraints
- Regulatory Concerns related to single-use bioreactors
- Opportunities
- Patent expiry
Challenges
- Concerns on sterility with use of single-use bioreactors
- Requirements for compatible and GMP certified sensors
- Implementation in single-use bioreactors workflow
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Sartorius Stedim Biotech
- Merck Kgaa
- Celltainer Biotech Bv.
- Getinge Ab
- Eppendorf Ag.
- Cellexus
- Pbs Biotech Inc.
- Distek Inc.
- Danaher Corporation
- Abec
- Able Corporation & Biott Corporation
- G&G Technologies Inc.
- Solida Biotech Gmbh
- Satake Chemical Equipment Mfg., Ltd.
- Stobbe Pharma Gmbh
- Bbi-Biotech Gmbh
For more information about this report visit https://www.researchandmarkets.com/r/55wm8t
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900